COVA4231, a potent CD3/CD33 bispecific FynomAb with IgG-like pharmacokinetics for the treatment of acute myeloid leukemia
2019
-
Correction
-
Source
-
Cite
-
Save
15
References
8
Citations
NaN
KQI